Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: histologic and immunohistochemical effects
- 29 February 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 50 (2) , 189-196
- https://doi.org/10.1016/s0190-9622(03)01837-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The risk of progression to invasive diseaseJournal of the American Academy of Dermatology, 2000
- Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretinBritish Journal of Dermatology, 1999
- Skin cancers in transplant patientsNephrology Dialysis Transplantation, 1998
- Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapyJournal of the European Academy of Dermatology and Venereology, 1998
- Low‐dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipientsJournal of the European Academy of Dermatology and Venereology, 1998
- Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.Journal of Clinical Oncology, 1995
- BENEFICIAL EFFECT OF LOW-DOSE SYSTEMIC RETINOID IN COMBINATION WITH TOPICAL TRETINOIN FOR THE TREATMENT AND PROPHYLAXIS OF PREMALIGNANT AND MALIGNANT SKIN LESIONS IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1995
- Retinoids to prevent skin cancer in organ transplant recipientsPublished by Elsevier ,1991
- PAPILLOMAVIRUS INFECTION AND SKIN CANCER IN RENAL ALLOGRAFT RECIPIENTSThe Lancet, 1989
- SKIN CANCER AND IMMUNOSUPPRESSIONThe Lancet, 1971